Related Experiment Videos
[Titration and dosage of gabapentin]
1Department of Neurology; Institut Clínic de Malalties del SN, Barcelona, 08036, España. santiago.arroyo@terra.es
Revista De Neurologia
|May 22, 2002
Summary
Gabapentin (GBP) can be rapidly titrated and higher doses (up to 4,800 mg/day) show increased efficacy for drug-resistant epilepsy without more adverse effects, making it a valuable treatment option.
Area of Science:
- Neurology
- Pharmacology
Background:
- Gabapentin (GBP) is an anti-epileptic drug for partial epilepsy.
- Unlike many anti-epileptic drugs, GBP allows for rapid dose titration.
Purpose of the Study:
- To evaluate the efficacy and safety of rapid titration and high-dose gabapentin therapy.
- To determine the optimal dosing strategy for gabapentin in epilepsy management.
Main Methods:
- Review of a double-blind trial and clinical trial data.
- Analysis of treatment outcomes with varying gabapentin dosages.
Main Results:
- Starting gabapentin at 900 mg/day (300 mg every 8 hours) is effective for recent-onset partial epilepsy monotherapy.
- Doses up to 4,800 mg/day significantly increase efficacy in drug-resistant epilepsy.
- Higher doses did not lead to a significant increase in adverse effects.
Conclusions:
- Gabapentin can be rapidly titrated.
- High-dose gabapentin (up to 4,800 mg/day) is advisable for drug-resistant epilepsy due to enhanced efficacy and comparable safety.
- Gabapentin offers a flexible and effective treatment option for epilepsy.